Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b. / Goodin, Douglas; Reder, Anthony; Traboulsee, Anthony; Li, David; Langdon, Dawn; Cutter, Gary; Cook, Stuart ; O'Donnell, Timothy; Kremenchutzky, Marcelo; Oger, Joel; Koelbach, Ralf; Pohl, Christoph; Wicklein, Eva-Maria.
In: Multiple Sclerosis Journal, 06.04.2018.Research output: Contribution to journal › Article
Original language | English |
---|---|
Journal | Multiple Sclerosis Journal |
State | Accepted/In press - 6 Apr 2018 |
ID: 29849677